Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Daily Digest.
Press releases published on June 17, 2025
DMi Partners Named to Inc.’s Best Workplaces List For the Second Time
GlobeNewswire
·
June 17, 2025
PHILADELPHIA, June 17, 2025 (GLOBE NEWSWIRE) -- DMi Partners (DMi), the award-winning full-service performance marketing agency specializing in affiliate, email, search, and social media marketing, is proud to announce it has been named in Inc.’s annual …
Enterprise CMOs Turn to Hybrid MaaS as Budgets Rise but Teams Hold Flat, New 2X–Avasant Study Finds
GlobeNewswire
·
June 17, 2025
MALVERN, Pa. and LOS ANGELES , June 17, 2025 (GLOBE NEWSWIRE) -- 2X, a leader in subscription-based marketing as a service (MaaS), today released a new report, “Rethinking B2B Marketing Execution: The Age of Execution Reinvention,” in partnership with …
Conveyor Marketing Group’s Survey of B2B Marketers Reveals Small to Mid-Sized Companies Lead the Pack in AI Knowledge and Success
GlobeNewswire
·
June 17, 2025
PHILADELPHIA, June 17, 2025 (GLOBE NEWSWIRE) -- Conveyor Marketing Group, a strategic digital marketing agency that drives measurable results, today released its “How AI Will Define B2B Marketing Success in 2030” report, providing insights into the AI …
Lipella Pharmaceuticals Announces U.S. Patent Issuance for Diagnostic Technology
GlobeNewswire
·
June 17, 2025
PITTSBURGH, June 17, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet need, today announced the …
ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart™ Test in Detecting Esophageal Cancer
GlobeNewswire
·
June 17, 2025
BE-Smart represents a significant advance in diagnosis and management of Esophageal disease that affects an estimated 60 million people in the United States Study shows >95% success rate, validating BE-Smart for use with esophageal brush cytology. …
Mineralys Therapeutics Announces Positive Topline Results from Phase 2 Explore-CKD Trial of Lorundrostat for the Treatment of Hypertension in Subjects with CKD and Albuminuria
GlobeNewswire
·
June 17, 2025
– Explore-CKD met its primary endpoint; lorundrostat 25 mg once daily achieved a 9.3 mmHg reduction in systolic blood pressure, and a 7.5 mmHg placebo-adjusted reduction (p=0.0024) at four weeks – – Lorundrostat showed a clinically meaningful reduction in …
AscellaHealth Wins Business Change and Transformation Excellence Award at the Industry Eagles Awards 2025
GlobeNewswire
·
June 17, 2025
DUBLIN and BERWYN, Pa., June 17, 2025 (GLOBE NEWSWIRE) -- We are proud to announce that AscellaHealth has been awarded Gold in the Business Change and Transformation Excellence category at the Industry Eagles Awards 2025, held on 5th June 2025 at The …